Skip to Main Content

Agenda

NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer CareTM

Thursday, March 23, 2017

7:00 - 8:00 AM


Breakfast, Exhibits, and General Poster Session (Exhibition Hall)


8:00 - 8:10 AM

Welcome and Opening Remarks

Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network


8:15 - 9:30 AM

NCCN Roundtable Discussion:
Emerging Issues in Oncology –
Addressing Health Disparities in Cancer Care from Diagnosis to Survivorship

Moderator: Clifford Goodman, PhD, Senior Vice President, The Lewin Group

Panelists: Shauntice Allen, PhD, University of Alabama at Birmingham Comprehensive Cancer Center;
Moon S. Chen, Jr., PhD, MPH, University of California Davis Comprehensive Cancer Center;
Anne Filipic, ​Enroll America; 
Edith Mitchell, MD, ​Sidney Kimmel Cancer Center at Jefferson;
Phyllis Pettit Nassi, MSW, Huntsman Cancer Institute at the University of Utah

This non-accredited roundtable will provide an opportunity for a varied group of stakeholders including providers,
payers, patient advocates, industry, and government to discuss disparities in cancer care among
minorities and medically underserved populations.

This roundtable is supported by Astellas; Taiho Oncology; and Janssen Oncology, a Pharmaceutical Company of Johnson & Johnson. Sponsored by AbbVie and Novartis. Supported by an educational grant from Agios and Takeda Oncology. Supported by an educational donation provided by Amgen. Sponsored by a financial contribution from Bristol-Myers Squibb. Supported by an unrestricted grant from Eisai Inc. This activity is supported by a contribution from Lilly.
This activity was made possible by Pharmacyclics LLC and Janssen Biotech, Inc..


9:30 - 9:50 AM


Break, Exhibits, and General Poster Session (Exhibition Hall)


9:50 - 10:35 AM

New Treatment Guidelines for Myeloproliferative Neoplasms and Myelofibrosis

Ruben A. Mesa, MD
Mayo Clinic Cancer Center


10:40 - 11:25 AM

Evolving Treatment of Soft Tissue Sarcoma

Suzanne George, MD
Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center


11:30 AM -12:15 PM

Multi-Gene Testing for Hereditary Cancer: When, Why, and How?

Kenneth Offit, MD
Memorial Sloan Kettering Cancer Center


12:15 - 1:45 PM


Lunch, Exhibits, and General Poster Session (Exhibition Hall)


1:45 - 3:15 PM

NCCN Guidelines® Updates: Non-Small Cell Lung Cancer

What, When, and How of Biomarker Testing in Non-Small Cell Lung Cancer

Gregory J. Riely, MD, PhD
Memorial Sloan Kettering Cancer Center

Biomarker-based Treatment Selection in Non-Small Cell Lung Cancer

Wallace Akerley, MD
Huntsman Cancer Institute at the University of Utah

Immunotherapies for Lung Cancer

Matthew A. Gubens, MD, MS
UCSF Helen Diller Family Comprehensive Cancer Center


3:15 - 3:40 PM


Break, Exhibits, and General Poster Session (Exhibition Hall)


3:40 - 4:25 PM

Incorporating New Systemic Therapies in Kidney Cancer Treatment

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center


4:30 – 5:15 PM

Challenges of Toxicity Management in Immuno-oncology

Stephanie Andrews, MS, ANP-BC
Moffitt Cancer Center


5:15 - 5:30 PM


Free Time


5:30 - 7:30 PM


Welcome Reception (Exhibition Hall)

 
Kids Movie Night (Location TBD)


 

Friday, March 24, 2017

7:00 - 8:00 AM


Breakfast, Exhibits, and General Poster Session (Exhibition Hall)


Breakfast Symposium§ 7:00 – 8:00 AM

Immuno-oncology Therapeutics for Renal Cell Carcinoma and Bladder Cancer:
Integrating the Latest Developments Into Clinical Practice


Jointly sponsored by NCCN and Clinical Care Options, LLC.

This activity is supported by educational grants from AstraZeneca and Genentech;
an independent medical education grant from Bristol-Myers Squibb;
and an independent educational grant from Merck Co., Inc.


8:00 - 8:10 AM


Opening Remarks


8:15 - 9:30 AM


Keynote Address:
When Breath Becomes Air – As Physician Becomes Patient

Lucy Kalanithi, MD
Widow of the late Dr. Paul Kalanithi, author of the #1 New York Times bestselling memoir, 
When Breath Becomes Air, for which she wrote the epilogue; 
Clinical Assistant Professor of Medicine, Stanford School of Medicine

Heather Wakelee, MD
Associate Professor of Medicine, Stanford Cancer Institute;
Treating Oncologist of the late Dr. Paul Kalanithi 

This keynote will provide an opportunity to discuss key inflection points during the course of a life-threatening illness and how they contribute to the complexity of relationships among patients, their families, and their health care professionals. Strategies to optimize communication between clinician-patient-family during the course of a
life-threatening illness as well as key factors to consider in developing an individual approach to
clinician-patient-family communication to ensure optimal care and informed decision-making will also be addressed.


9:30 - 9:55 AM


Break, Exhibits, and General Poster Session (Exhibition Hall)


9:55 - 10:40 AM

Opportunities and Challenges: Human Papillomavirus and Cancer

Christina S. Chu, MD
Fox Chase Cancer Center

David G. Pfister, MD
Memorial Sloan Kettering Cancer Center


10:45 AM - 12:15 PM


NCCN Guidelines® Updates: Breast Cancer

Evolving Radiation Therapy Recommendations for Breast Cancer

Kilian E. Salerno, MD
Roswell Park Cancer Institute

Use of Biomarkers and Multigene Assays in Breast Cancer

Lee S. Schwartzberg, MD
The University of Tennessee Health Science Center

New Approaches to Endocrine Therapy for Breast Cancer

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University


12:15 - 1:45 PM


Lunch, Exhibits, and General Poster Session (Exhibition Hall)


Lunch Symposium§ 12:25 – 1:40 PM

Examining Health Policy, Payer, Provider, and Patient Perspectives in Indolent Non-Hodgkin’s Lymphoma

Presented by NCCN and PRIME® Education, LCC.

There is no fee for this activity as it is sponsored by PRIME through
educational grants from AbbVie, Inc and Gilead Sciences, Inc. 


1:45 - 2:30 PM


Smoking Cessation in Patients with Cancer: Treatment Advances and the Oncologist’s Role

Paul M. Cinciripini, PhD
The University of Texas MD Anderson Cancer Center


2:35 - 3:20 PM


Novel Treatment Options for Neuroendocrine Tumors

Matthew H. Kulke, MD, MMSc
Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center


3:20 - 3:40 PM


Break and Exhibits (Exhibition Hall)


3:40 - 4:25 PM


New Options in the Management of Multiple Myeloma

Shaji K. Kumar, MD
Mayo Clinic Cancer Center


4:30 - 5:15 PM


Updates to the Management of Advanced Bladder Cancer

Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center


 

5:30 - 7:15 PM

 

 Dinner Symposium§ 6:00 – 7:15 PM

Insights on Individualizing Treatment of Patients with Multiple Myeloma

Presented by NCCN.

This activity is supported by educational funding provided by Amgen and
educational grants from Celgene Corporation and Janssen Biotech, Inc.







 Saturday, March 25, 2017

7:00 - 8:00 AM


Breakfast (Gatlin Ballroom Foyer)


8:00 - 8:10 AM


Opening Remarks


8:15 - 9:00 AM


Minimally Invasive Techniques for Treating Gynecologic Malignancies

Amanda Nickles Fader, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


9:05 - 9:50 AM


Chronic Lymphocytic Leukemia: Individualizing Treatment Approach

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center


9:50 - 10:10 AM


Break (Gatlin Ballroom Foyer)


10:10 - 10:55 AM


Active Systemic Treatment of Pancreatic Cancer

Margaret A. Tempero, MD
UCSF Helen Diller Family Comprehensive Cancer Center


11:00 - 11:45 AM


Implications of the New AJCC Staging System


Stephen B. Edge, MD
Roswell Park Cancer Institute

11:45 - 12:30 PM


Lunch (Gatlin Ballroom Foyer)


12:30 - 1:15 PM


Life After Treatment: Quality of Life Concerns in Patients Treated for Cancer

Mindy E. Goldman, MD
UCSF Helen Diller Family Comprehensive Cancer Center


1:20 - 2:05 PM


Strategies for Management of Relapsed/Refractory Hodgkin Lymphoma

Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University


2:10 - 2:55 PM


Systemic Management of Colorectal Cancer

Wells Messersmith, MD
University of Colorado Cancer Center


2:55 - 3:00 PM


Closing Remarks


 

§ These symposia are open to all health care providers attending the conference; pre-registration is not required.
CME/CNE/CPE available. The symposia are accredited and supported separately from all other educational sessions on this agenda.
Seating is limited and on a first-come, first-seated basis.


Agenda is subject to change.

Top